Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape; New Report Launched
The company's latest report states that the stem cell therapy pipeline as a whole is relatively large, with 330 products in active development across all stages. Indeed, R&D within the sector is gaining momentum as candidates move into clinical development, and the results of clinical studies become apparent, clarifying the therapeutic potential of stem cell therapy.
View full press release